SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
新闻
CALA
--
0.00%
--
Edited Transcript of CALA earnings conference call or presentation 7-May-20 9:00pm GMT
Thomson Reuters StreetEvents · 11小时前
Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 2天前
Calithera Biosciences To Present Telaglenastat KEAPSAKE Trial In Progress Poster At ASCO
Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, today
Benzinga · 6天前
Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at ASCO20 Virtual Annual Meeting
The KEAPSAKE study (NCT04265534) will explore telaglenastat versus placebo in combination with a standard-of-care regimen of immunotherapy and chemotherapy as first-line treatment for patients with non-small cell lung cancers (NSCLC) with KEAP1/NRF2 mutations.
GlobeNewswire · 6天前
Calithera to Present at the Jefferies Virtual Healthcare Conference
Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially block tumor cells and enhance immune-cell activity. Driven by a commi
GlobeNewswire · 05/27 11:01
Has Calithera Biosciences (CALA) Outpaced Other Medical Stocks This Year?
Zacks · 05/18 16:30
Is Calithera Biosciences (CALA) Stock a Solid Choice Right Now?
Zacks · 05/13 14:15
What Makes Calithera (CALA) a New Buy Stock
Zacks · 05/11 17:00
Circling Back On Calithera Biosciences
Seeking Alpha - Article · 05/11 09:58
Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 20:09
Calithera Biosciences Inc (CALA) Q1 2020 Earnings Call Transcript
Motley Fool · 05/08 18:01
HC Wainwright & Co. Reiterates Buy on Calithera Biosciences, Raises Price Target to $9.5
HC Wainwright & Co. reiterates Calithera Biosciences (NASDAQ:CALA) with a Buy and raises the price target from $7 to $9.5.
Benzinga · 05/08 11:16
Calithera Biosciences EPS misses by $0.02
Calithera Biosciences (NASDAQ:CALA): Q1 GAAP EPS of -$0.38 misses by $0.02. Cash, equivalents and investments of $138.11M (-12.2% Q/Q) Press Release
seekingalpha · 05/08 01:09
Calithera Biosciences Reports First Quarter 2020 Financial Results and Recent Highlights
GlobeNewswire · 05/07 21:05
Calithera Biosciences Q1 EPS $(0.380) Misses $(0.360) Estimate
Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.380) per share which missed the analyst consensus estimate of $(0.360) by 5.56 percent. This is a 37.7 percent increase over losses of $(0.610) per
Benzinga · 05/07 20:58
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.)
Benzinga · 05/07 11:42
Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
One-fourth of the option vests on April 6, 2021, and the balance of the option vests in a series of thirty-six successive equal monthly installments thereafter and was granted pursuant to the Calithera Biosciences, Inc. 2018 Inducement Plan, or Inducement Plan
GlobeNewswire · 05/06 11:05
Cramer's lightning round: 'If I really want solar, I want Tesla'
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 05/04 23:20
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc.
Benzinga · 05/03 12:46
Cramer's lightning round: I am worried about Twilio
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 05/01 23:13